HealthThis mRNA vaccine could potentially prevent the deadliest form of skin cancer

Moderna and Merck say a personalized mRNA cancer vaccine used with Keytruda reduced the risk of melanoma returning and spreading in high-risk patients. Dr. Jon LaPook and trial researcher Dr. Janice Mehnert provide more information.